Nordhealth (Norway) Performance
| NORDH Stock | 37.50 0.10 0.27% |
Nordhealth has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.94, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Nordhealth are expected to decrease slowly. On the other hand, during market turmoil, Nordhealth is expected to outperform it slightly. Nordhealth AS right now secures a risk of 4.41%. Please verify Nordhealth AS expected short fall, and the relationship between the value at risk and daily balance of power , to decide if Nordhealth AS will be following its current price movements.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nordhealth AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Nordhealth may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 3.8 M | |
| Total Cashflows From Investing Activities | -92.1 M |
Nordhealth |
Nordhealth Relative Risk vs. Return Landscape
If you would invest 3,600 in Nordhealth AS on August 24, 2024 and sell it today you would earn a total of 140.00 from holding Nordhealth AS or generate 3.89% return on investment over 90 days. Nordhealth AS is generating 0.1541% of daily returns and assumes 4.4114% volatility on return distribution over the 90 days horizon. Simply put, 39% of stocks are less volatile than Nordhealth, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Nordhealth Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nordhealth's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nordhealth AS, and traders can use it to determine the average amount a Nordhealth's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0349
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NORDH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.41 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Nordhealth is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nordhealth by adding it to a well-diversified portfolio.
Nordhealth Fundamentals Growth
Nordhealth Stock prices reflect investors' perceptions of the future prospects and financial health of Nordhealth, and Nordhealth fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nordhealth Stock performance.
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0552 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.37) % | |||
| Current Valuation | 1.21 B | |||
| Shares Outstanding | 45.19 M | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 60.29 X | |||
| Revenue | 20.3 M | |||
| EBITDA | (369 K) | |||
| Total Debt | 25 K | |||
| Book Value Per Share | 1.28 X | |||
| Cash Flow From Operations | 5.57 M | |||
| Earnings Per Share | (1.05) X | |||
| Total Asset | 125.13 M | |||
About Nordhealth Performance
By examining Nordhealth's fundamental ratios, stakeholders can obtain critical insights into Nordhealth's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nordhealth is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Nordhealth AS performance evaluation
Checking the ongoing alerts about Nordhealth for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nordhealth AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nordhealth AS had very high historical volatility over the last 90 days | |
| Nordhealth AS has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 20.3 M. Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 6.67 M. |
- Analyzing Nordhealth's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nordhealth's stock is overvalued or undervalued compared to its peers.
- Examining Nordhealth's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nordhealth's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nordhealth's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nordhealth's stock. These opinions can provide insight into Nordhealth's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Nordhealth Stock
Nordhealth financial ratios help investors to determine whether Nordhealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nordhealth with respect to the benefits of owning Nordhealth security.